Oncology & Cancer

Study validates therapy for aggressive bladder cancer

Findings from a new study led by Yale Cancer Center researchers show enfortumab vedotin is effective in patients with muscle-invasive bladder cancer (MIBC) not eligible for cisplatin chemotherapy. The data is from Cohort ...

Oncology & Cancer

The evidence is in: COVID vaccines do protect patients with cancer

The long-awaited confirmation of the efficacy of COVID-19 vaccination in patients with cancer has arrived, on time to be disseminated to a global audience at the annual congress of the European Society for Medical Oncology, ...

page 7 from 39